as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
2.07%
Downside
0.41%
Upside
52 Week's Low
52 Week's High
24.79%
Downside
27.69%
Upside
Check Oramed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$98.8M
EPS (TTM)
-0.34
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.41%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-13.5M
Revenue (TTM)
2.0M
Profit Margin
0.00%
Return On Equity TTM
16876800.00%
Compare market cap, revenue, PE, and other key metrics of Oramed Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
HOLD | $98.8M | NA | NA | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Oramed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Oramed Pharmaceuticals Inc investment value today
Current value as on today
₹1,02,328
Returns
₹2,328
(+2.33%)
Returns from Oramed Pharmaceuticals Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 7 analysts
0.00%
Buy
57.14%
Hold
42.86%
Sell
Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for Oramed Pharmaceuticals Inc. Average target price of $3.25
Get share price movements and forecasts by analysts on Oramed Pharmaceuticals Inc.
What analysts predicted
25.54%UPSIDE
Target Price
$3.25
Current Price
$2.42
Analyzed by
7 Analysts
Target
$3.25
Oramed Pharmaceuticals Inc target price $3.25, a slight upside of 25.54% compared to current price of $2.42. According to 7 analysts rating.
Search interest for Oramed Pharmaceuticals Inc Stock has increased by 110% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:110% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, ORMP stock has moved up by 6.7%
Profit Spike
Netprofit is up for the last 4 quarters, -19.61M → 13.28M (in $), with an average increase of 94.5% per quarter
Revenue Rich
Revenue is up for the last 4 quarters, 666.0K → 2.0M (in $), with an average increase of 22.5% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 80.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 198.8%
Organisation | Oramed Pharmaceuticals Inc |
Headquarters | 1185 Avenue of the Americas, New York, NY, United States, 10036 |
Industry | Health Technology |
CEO | Mr. Nadav Kidron Esq. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Nadav Kidron Esq. | President, CEO & Executive Chairman |
Mr. Avraham Gabay | CFO, Treasurer & Secretary |
Mr. Joshua Hexter | Chief Operating & Business Officer |
Dr. Miriam Kidron Ph.D. | Chief Scientific Officer & Director |
Oramed Pharmaceuticals Inc share price today is $2.42 as on at the close of the market. Oramed Pharmaceuticals Inc share today touched a day high of $2.43 and a low of $2.37.
Oramed Pharmaceuticals Inc share touched a 52 week high of $3.09 on and a 52 week low of $1.82 on . Oramed Pharmaceuticals Inc stock price today i.e. is closed at $2.42,which is 21.68% down from its 52 week high and 32.97% up from its 52 week low.
Oramed Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Oramed Pharmaceuticals Inc (ORMP) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Oramed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Oramed Pharmaceuticals Inc share’s latest price of $2.42 as on September 13, 2025 at 1:29 am IST, you will get 4.1322 shares of Oramed Pharmaceuticals Inc. Learn more about
fractional shares .